Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Debt / Cv 5.0%
-
Market price (% of par)
-
66.25%
-
Total 13F principal
-
$34,008,227
-
Principal change
-
+$28,957,964
-
Total reported market value
-
$22,686,790
-
Number of holders
-
6
-
Value change
-
+$19,066,052
-
Number of buys
-
5
Institutional Holders of Accelerate Diagnostic - Cv 5.0% as of Q4 2023
As of 31 Dec 2023,
Accelerate Diagnostic - Cv 5.0% was held by
6 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$34,008,227
in principal (par value) of the bond.
The largest 6 bondholders included
Indaba Capital Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, Bruce & Co., Inc., PenderFund Capital Management Ltd., CREDIT SUISSE AG/, and INGALLS & SNYDER LLC.
This page lists
6
institutional bondholders reporting positions
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.